Information Provided By:
Fly News Breaks for February 20, 2018
NHI
Feb 20, 2018 | 09:15 EDT
SunTrust analyst Eric Fleming lowered his price target on National Health Investors to $70 on valuation, but says that the company is executing with its "stable portfolio and a solid pipeline despite the headline industry issues". The analyst adds that National Health Investors' FY18 guidance captures its 5% annual growth target, and the company's portfolio issues are trending positively in Q3. Fleming keeps his Hold rating on National Health Investors.
News For NHI From the Last 2 Days
There are no results for your query NHI